34th AM (2023) - Poster Session-Substance Use Along the Spectrum of Borderline Personality Disorder

Substance Use Along the Spectrum of Borderline Personality Disorder

Pdf Summary

This study aimed to explore the relationship between substance use and Borderline Personality Disorder (BPD), as well as the severity of substance use among individuals with different degrees of BPD symptomatology. <br /><br />The study involved screening adults from a single site for BPD using the Standardized Clinical Interview for the DSM-V. Participants were categorized into three groups: not having BPD traits, having some BPD traits, and meeting full BPD criteria. The level of substance use was measured using the World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO-ASSIST), which provided scores for overall substance use and sub-scores for 10 different substances. <br /><br />The results showed significant differences in substance use severity among the three groups. The overall substance use score and sub-scores for cannabis, tobacco, alcohol, cocaine, amphetamines, inhalants, hallucinogens, opioids, and sedatives were significantly different among the three groups. <br /><br />Overall, the findings of this study suggest a stepwise relationship between the severity of substance use and BPD symptomatology. The study highlights the high prevalence of substance use among individuals with BPD and emphasizes the need for further research to understand the underlying mechanisms linking BPD traits and substance use. <br /><br />This study adds to the existing literature on the comorbidity of BPD and substance use disorders and provides valuable insights for clinicians and researchers working in the field. The findings contribute to the current understanding of the complex relationship between BPD and substance use, emphasizing the importance of addressing substance use issues in individuals with BPD.

Keywords

substance use

Borderline Personality Disorder

BPD

severity

BPD symptomatology

screening

Standardized Clinical Interview

DSM-V

substance use severity

World Health Organization

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 307 East Providence, RI 02914 cmecpd@aaap.org	About Advocacy Membership Fellowship Education and Resources Training Events